{"transactions":[{"id":857949,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:50:10.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 3, 2027, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":190000,"derivative":{"exercise_price":9.36,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0000905148-26-001177","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514826001177/form4.xml","form_type":"4"}},{"id":1078959,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2025-07-30T21:51:10.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80000,"source":{"system":"sec-edgar","filing":"0000905148-25-002657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514825002657/form4.xml","form_type":"4"}},{"id":1216898,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T21:36:57.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":107500,"derivative":{"exercise_price":14.95,"expiration_date":"2035-03-05","underlying":"Ordinary Shares","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0000905148-25-000885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514825000885/form4.xml","form_type":"4"}},{"id":1609484,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-01T02:06:06.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":30.3,"expiration_date":"2034-02-27","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000905148-24-000837","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514824000837/form4.xml","form_type":"4"}},{"id":1772512,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-28T00:35:53.000Z","date":"2023-09-27","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":90000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000905148-23-001024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823001024/form4.xml","form_type":"4"}},{"id":1772511,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-09-28T00:35:53.000Z","date":"2023-09-27","kind":"sale","planned":true,"acquired":false,"shares":404,"price":48.3148,"value":19519.1792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $47.975 to $48.4525, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823001024/form4.xml","form_type":"4"}},{"id":1772510,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-09-28T00:35:53.000Z","date":"2023-09-27","kind":"sale","planned":true,"acquired":false,"shares":4596,"price":47.2945,"value":217365.522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $46.975 to $47.945, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":404,"source":{"system":"sec-edgar","filing":"0000905148-23-001024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823001024/form4.xml","form_type":"4"}},{"id":1772509,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-09-28T00:35:53.000Z","date":"2023-09-27","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000905148-23-001024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823001024/form4.xml","form_type":"4"}},{"id":1792780,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-30T23:24:55.000Z","date":"2023-08-30","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":95000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000905148-23-000803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823000803/form4.xml","form_type":"4"}},{"id":1792779,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-30T23:24:55.000Z","date":"2023-08-30","kind":"sale","planned":true,"acquired":false,"shares":14,"price":56.21,"value":786.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-000803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823000803/form4.xml","form_type":"4"}},{"id":1792778,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-30T23:24:55.000Z","date":"2023-08-30","kind":"sale","planned":true,"acquired":false,"shares":2664,"price":55.3871,"value":147551.2344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $55.16 to $55.755, inclusive."}],"balance_after":14,"source":{"system":"sec-edgar","filing":"0000905148-23-000803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823000803/form4.xml","form_type":"4"}},{"id":1792777,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-30T23:24:55.000Z","date":"2023-08-30","kind":"sale","planned":true,"acquired":false,"shares":2322,"price":54.577,"value":126727.794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $54.09 to $55.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":2678,"source":{"system":"sec-edgar","filing":"0000905148-23-000803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823000803/form4.xml","form_type":"4"}},{"id":1792776,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-30T23:24:55.000Z","date":"2023-08-30","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000905148-23-000803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514823000803/form4.xml","form_type":"4"}},{"id":1822689,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T23:45:23.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-036291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123036291/form4.xml","form_type":"4"}},{"id":1822688,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-26T23:45:23.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":620,"price":63.4017,"value":39309.054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $63.285 to $64.04, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-036291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123036291/form4.xml","form_type":"4"}},{"id":1822687,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-26T23:45:23.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":1903,"price":62.6891,"value":119297.3573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $62.27 to $63.235, inclusive."}],"balance_after":620,"source":{"system":"sec-edgar","filing":"0001140361-23-036291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123036291/form4.xml","form_type":"4"}},{"id":1822686,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-26T23:45:23.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":2477,"price":61.7811,"value":153031.7847,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $61.25 to $62.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":2523,"source":{"system":"sec-edgar","filing":"0001140361-23-036291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123036291/form4.xml","form_type":"4"}},{"id":1822685,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-26T23:45:23.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-036291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123036291/form4.xml","form_type":"4"}},{"id":1842541,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T00:45:36.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":105000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-032003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123032003/form4.xml","form_type":"4"}},{"id":1842540,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-29T00:45:36.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":710,"price":70.8386,"value":50295.406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $70.48 to $71.07, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-032003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123032003/form4.xml","form_type":"4"}},{"id":1842539,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-29T00:45:36.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":3050,"price":69.8944,"value":213177.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $69.47 to $70.345, inclusive."}],"balance_after":710,"source":{"system":"sec-edgar","filing":"0001140361-23-032003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123032003/form4.xml","form_type":"4"}},{"id":1842538,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-29T00:45:36.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":1240,"price":69.068,"value":85644.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $68.425 to $69.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":3760,"source":{"system":"sec-edgar","filing":"0001140361-23-032003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123032003/form4.xml","form_type":"4"}},{"id":1842537,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-29T00:45:36.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-032003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123032003/form4.xml","form_type":"4"}},{"id":1873127,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T01:30:44.000Z","date":"2023-05-31","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":110000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-027617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123027617/form4.xml","form_type":"4"}},{"id":1873126,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-01T01:30:44.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":711,"price":65.9813,"value":46912.7043,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $65.75 to $66.255, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-027617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123027617/form4.xml","form_type":"4"}},{"id":1873125,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-01T01:30:44.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":1078,"price":65.2001,"value":70285.7078,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $64.73 to $65.72, inclusive."}],"balance_after":711,"source":{"system":"sec-edgar","filing":"0001140361-23-027617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123027617/form4.xml","form_type":"4"}},{"id":1873124,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-01T01:30:44.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":3211,"price":64.1621,"value":206024.5031,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $63.705 to $64.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":1789,"source":{"system":"sec-edgar","filing":"0001140361-23-027617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123027617/form4.xml","form_type":"4"}},{"id":1873123,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-01T01:30:44.000Z","date":"2023-05-31","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-027617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123027617/form4.xml","form_type":"4"}},{"id":1911163,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:30:39.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-021747","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123021747/form4.xml","form_type":"4"}},{"id":1911162,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-29T01:30:39.000Z","date":"2023-04-26","kind":"sale","planned":true,"acquired":false,"shares":320,"price":54.2524,"value":17360.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $54.01 to $54.38, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-021747","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123021747/form4.xml","form_type":"4"}},{"id":1911161,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-29T01:30:39.000Z","date":"2023-04-26","kind":"sale","planned":true,"acquired":false,"shares":4680,"price":53.4042,"value":249931.656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $52.865 to $53.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":320,"source":{"system":"sec-edgar","filing":"0001140361-23-021747","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123021747/form4.xml","form_type":"4"}},{"id":1911160,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-29T01:30:39.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-021747","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123021747/form4.xml","form_type":"4"}},{"id":1933765,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-01T01:31:52.000Z","date":"2023-03-29","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-015527","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123015527/form4.xml","form_type":"4"}},{"id":1933764,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-01T01:31:52.000Z","date":"2023-03-29","kind":"sale","planned":true,"acquired":false,"shares":2266,"price":49.2794,"value":111667.1204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $49.05 to $49.505, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-015527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123015527/form4.xml","form_type":"4"}},{"id":1933763,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-01T01:31:52.000Z","date":"2023-03-29","kind":"sale","planned":true,"acquired":false,"shares":2734,"price":48.8135,"value":133456.109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $48.02 to $49.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":2266,"source":{"system":"sec-edgar","filing":"0001140361-23-015527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123015527/form4.xml","form_type":"4"}},{"id":1933762,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-04-01T01:31:52.000Z","date":"2023-03-29","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-015527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123015527/form4.xml","form_type":"4"}},{"id":1946018,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-18T01:31:08.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-23-005290","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761923005290/doc1.xml","form_type":"4"}},{"id":1946017,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-18T01:31:08.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":8564,"price":48.6688,"value":416799.6032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $48.435 to $49.13, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-23-005290","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761923005290/doc1.xml","form_type":"4"}},{"id":1946016,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-18T01:31:08.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":6436,"price":48.1343,"value":309792.3548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $47.43 to $48.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":8564,"source":{"system":"sec-edgar","filing":"0001567619-23-005290","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761923005290/doc1.xml","form_type":"4"}},{"id":1946015,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-18T01:31:08.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":15000,"price":10.27,"value":154050.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001567619-23-005290","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761923005290/doc1.xml","form_type":"4"}},{"id":1971822,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T02:31:16.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":48000,"derivative":{"exercise_price":52.97,"expiration_date":"2033-03-02","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001140361-23-010187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123010187/form4.xml","form_type":"4"}},{"id":2097800,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":140000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097799,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":176,"price":65.8659,"value":11592.3984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $65.82 to $65.94, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097798,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":411,"price":64.9577,"value":26697.6147,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $64.82 to $65.725, inclusive."}],"balance_after":176,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097797,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":494,"price":64.1262,"value":31678.3428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $63.82 to $64.815, inclusive."}],"balance_after":587,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097796,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":456,"price":62.853,"value":28660.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $62.575 to $63.295, inclusive."}],"balance_after":1081,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097795,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":1625,"price":62.0633,"value":100852.8625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $61.57 to $62.56, inclusive."}],"balance_after":1537,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097794,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":1696,"price":60.9584,"value":103385.4464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $60.565 to $61.50, inclusive."}],"balance_after":3162,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097793,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":142,"price":59.9172,"value":8508.2424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $59.32 to $60.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 8 of this Form 4."}],"balance_after":4858,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2097792,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:33.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":5000,"price":10.27,"value":51350.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-22-044321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122044321/form4.xml","form_type":"4"}},{"id":2130233,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-27","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":145000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130232,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-26","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":165000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130231,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":20000,"price":62.0002,"value":1240004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $62.00 to $62.06, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130230,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-27","kind":"exercise","acquired":true,"shares":20000,"price":10.27,"value":205400.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130229,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":19720,"price":61.117,"value":1205227.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $60.815 to $61.49, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130228,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":29572,"price":60.271,"value":1782334.012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $59.785 to $60.775, inclusive."}],"balance_after":19720,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130227,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":15708,"price":59.3701,"value":932585.5308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $58.785 to $59.78, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 5 of this Form 4."}],"balance_after":49292,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2130226,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-29T01:30:35.000Z","date":"2022-10-26","kind":"exercise","acquired":true,"shares":65000,"price":10.27,"value":667550.0,"ownership":{"direct":true},"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001567619-22-018925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922018925/doc1.xml","form_type":"4"}},{"id":2371467,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-26T02:30:46.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 23, 2023 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":32.45,"expiration_date":"2032-02-23","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001140361-22-006888","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122006888/form4.xml","form_type":"4"}},{"id":2502272,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-20T02:32:54.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable as to 25% of the total number of shares subject to the option on July 1, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":230000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-020909","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921020909/doc1.xml","form_type":"4"}},{"id":2502271,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-11-20T02:32:54.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":10000,"price":55,"value":550000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-020909","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921020909/doc1.xml","form_type":"4"}},{"id":2502270,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-11-20T02:32:54.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":10000,"price":10.27,"value":102700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-21-020909","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921020909/doc1.xml","form_type":"4"}},{"id":2531615,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest and become exercisable as to 25% of the total number of shares subject to the option on July 1, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":240000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2531614,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":20,"price":60.885,"value":1217.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $60.88 to $60.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2531613,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":1066,"price":60.0307,"value":63992.7262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $59.52 to $60.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":20,"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2531612,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":2950,"price":58.8839,"value":173707.505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $58.52 to $59.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1086,"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2531611,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":5964,"price":58.0704,"value":346331.8656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $57.35 to $58.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4036,"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2531610,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-10-29T21:00:49.000Z","date":"2021-10-27","kind":"exercise","acquired":true,"shares":10000,"price":10.27,"value":102700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-21-019011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921019011/doc1.xml","form_type":"4"}},{"id":2829035,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:11:12.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":56000,"derivative":{"exercise_price":22.6,"expiration_date":"2031-02-25","underlying":"Ordinary Shares","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001567619-21-005083","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921005083/doc1.xml","form_type":"4"}},{"id":3243208,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T22:19:37.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":12.15,"expiration_date":"2030-02-25","underlying":"Ordinary Shares","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001567619-20-005022","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761920005022/doc1.xml","form_type":"4"}},{"id":3467346,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":62512,"kind":"person","name":"Malecek Michael J","position":1,"cik":"0001779336","reported_name":"Malecek Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T18:10:24.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on July 1, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":10.27,"expiration_date":"2029-07-01","underlying":"Ordinary Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-19-014388","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761919014388/doc1.xml","form_type":"4"}}]}